Skip to main
SGMO
SGMO logo

Sangamo Therapeutics (SGMO) Market Capitalization Overview

Market Cap: $120.74M as of Jul 11, 2025

$120.74M
Past Month-$5.72M (4.52%)
As of Jul 11, 2025, Sangamo Therapeutics (SGMO) has a market capitalization of $120.74M. Over the past 30 days, its market cap has increased by 13.39%, while in the last 12 months, it has decreased by -43.27%.

Market capitalization represents the total value of Sangamo Therapeutics as perceived by the stock market. It is calculated by multiplying the current stock price by the total number of outstanding shares.

Sangamo Therapeutics (SGMO) Market Cap Formula = Stock Price * Shares Outstanding

The market cap of Sangamo Therapeutics (SGMO) helps investors assess the company's size and compare it with competitors for better investment decisions.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

Sangamo Therapeutics (SGMO) Market Cap History

DateMarket CapChange
Jul 1, 2025$131.59M+13.39%
Jun 2, 2025$116.06M-30.32%
May 1, 2025$166.56M+30.01%
Apr 1, 2025$128.11M-33.30%
Mar 3, 2025$192.06M-21.32%
Feb 3, 2025$244.12M+3.54%
Jan 2, 2025$235.78M-52.12%

Sangamo Therapeutics (SGMO) End of Year Market Cap History

DateMarket CapChange
2025$120.74M-43.27%
2024$212.82M+120.88%
2023$96.36M-81.28%
2022$514.59M-52.90%
2021$1.10B-50.50%
2020$2.21B

FAQs About Sangamo Therapeutics (SGMO) Market Cap

As of Jul 11, 2025, the market capitalization of Sangamo Therapeutics (SGMO) is $120.74M. Market cap represents the total value of a company’s outstanding shares and is a key indicator of its size in the stock market.

In the last 30 days, Sangamo Therapeutics’s market capitalization has decreased by -4.52%, changing from $126.46M to $120.74M as of Jul 11, 2025.

In the last 3 months, Sangamo Therapeutics’s market capitalization has increased by —, changing from – to – as of –.

In the year 2024, Sangamo Therapeutics’s market capitalization increased from $96.36M in January to $212.82M in December, reflecting a 120.88% change.

In the past five years, Sangamo Therapeutics (SGMO) has had a compound annual growth rate (CAGR) of -37.36% in market capitalization. This means its market cap has shrunk at an average rate of -37.36% per year.

Sangamo Therapeutics (SGMO)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.